Press Releases

    • SEP 16 2019

    Oncoceutics Commemorates National Childhood Cancer Awareness Month

    Philadelphia, PA (September 16, 2019) – Oncoceutics, a clinical-stage drug discovery and development company, commemorates National Childhood Cancer Awareness Month this September and reiterates its support for children and all those affected by childhood cancer. Cancer remains one of the greatest current health challenges, and childhood cancer kills more children in the United States than

    • SEP 10 2019

    Publication Reports Clinical Efficacy of ONC201 in Expanded Access H3 K27M-mutant Glioma Patients

    Philadelphia, PA (September 10, 2019) – Oncoceutics, Inc. announced a scientific publication in the Journal of Neuro-Oncology describing a complete response and other forms of clinical benefit in pediatric and adult H3 K27M-mutant glioma patients treated with ONC201 on expanded access protocols. This manuscript details radiographic findings and other clinical outcomes in eighteen H3 K27M-mutant